TRANZYME INC (TZYM) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 39 transactions totaling $15.5M, demonstrating a bullish sentiment with $15.5M in net insider flow. The most recent transaction on Mar 14, 2012 involved a purchase of 1,482 shares valued at $4.4K.
No significant insider buying has been recorded for TZYM in the recent period.
No significant insider selling has been recorded for TZYM in the recent period.
Based on recent SEC filings, insider sentiment for TZYM is bullish with an Insider Alignment Score of 100/100 and a net flow of $15.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at TRANZYME INC (TZYM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading TZYM stock, having executed 39 transactions in the past 90 days. The most active insider is Capital Inc. Bdc (Executive), who has made 4 transactions totaling $4.0M.
Get notified when executives and directors at TZYM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 14, 2012 | Baker Julian | Executive | Purchase | 1,482 | $2.99 | $4.4K | |
| Mar 14, 2012 | Baker Julian | Executive | Purchase | 910 | $3.01 | $2.7K | |
| Mar 14, 2012 | Capital (gp), Llc Baker Biotech | Executive | Purchase | 4,592 | $3.01 | $13.8K | |
| Mar 14, 2012 | Capital (gp), Llc Baker Biotech | Executive | Purchase | 7,484 | $2.99 | $22.4K | |
| Mar 14, 2012 | Baker Felix | Executive | Purchase | 56,294 | $2.99 | $168.3K | |
| Mar 14, 2012 | Baker Felix | Executive | Purchase | 34,544 | $3.01 | $104.0K | |
| Mar 13, 2012 | Baker Julian | Executive | Purchase | 4,186 | $2.96 | $12.4K | |
| Mar 13, 2012 | Capital (gp), Llc Baker Biotech | Executive | Purchase | 15,599 | $2.96 | $46.2K | |
| Mar 13, 2012 | Baker Felix | Executive | Purchase | 159,015 | $2.96 | $470.7K | |
| Mar 12, 2012 | Baker Julian | Executive | Purchase | 15,076 | $2.55 | $38.4K | |
| Mar 12, 2012 | Baker Julian | Executive | Purchase | 8,628 | $2.34 | $20.2K | |
| Mar 12, 2012 | Baker Julian | Executive | Purchase | 1,170 | $1.87 | $2.2K | |
| Mar 12, 2012 | Baker Julian | Executive | Purchase | 430 | $1.89 | $813 | |
| Mar 12, 2012 | Capital (gp), Llc Baker Biotech | Executive | Purchase | 1,601 | $1.89 | $3.0K | |
| Mar 12, 2012 | Capital (gp), Llc Baker Biotech | Executive | Purchase | 4,363 | $1.87 | $8.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 28 | $15.5M | 100.0% |
Conversion(C) | 11 | $0 | 0.0% |
Insiders at TRANZYME INC are accumulating shares at an accelerated pace. With 9 insiders making 39 transactions totaling $15.5M in purchases versus $0 in sales, the net buying activity of $15.5M signals strong executive confidence. Capital Inc. Bdc (Executive) leads the buying activity with $4.0M in transactions across all time.